Prolonged treatment of patients with cancer associated thromboembolism (CAT). mapping of treatment landscape based on a German statutory health insurance (SHI) claims data analysis [CERTIFICAT].
Albrecht Kretzschmar(Roche (Switzerland)), Hanno Riess(Charité - Universitätsmedizin Berlin), Melanie May(Greenwood Genetic Center), Andreas Heinken(Bavarian Nordic (Germany))
Cited by 0
Related Papers
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
|European Journal of Cancer|2011|615
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
|Annals of Oncology|2009|534
Allan-Herndon-Dudley Syndrome and the Monocarboxylate Transporter 8 (MCT8) Gene
|The American Journal of Human Genetics|2005|369